HealthQuill rare disorders
Pfizer’s haemophilia A gene therapy has reduced bleeding rates in patients during an end-stage trial, according to a company statement.
Drugs Health Pharma

Pfizer’s haemophilia A gene therapy cuts bleeding rates during trials

HQ Team July 25, 2024: Pfizer’s haemophilia A gene therapy has reduced bleeding rates in patients during an end-stage trial, according to a.

Read More
The Food and Drug Administration has cleared X4 Pharmaceutical’s drug to treat a rare genetic disease that occurs in one in five million births.
Drugs Health Pharma

X4 Pharmaceutical’s drug to fight WHIM syndrome gets green light

HQ Team April 30, 2024: The Food and Drug Administration has cleared X4 Pharmaceutical’s drug to treat a rare genetic disease that occurs.

Read More
India has granted a complete customs duty exemption for the personal use of medicines to treat rare diseases, including Merc & Co’s Keytruda for cancer therapy.
Drugs Health Pharma

India fully exempts import tax for drugs treating rare diseases

India has granted a complete customs duty exemption for the personal use of medicines to treat rare diseases, including Merc & Co’s Keytruda.

Read More